相似文献
1
Stroke, high blood pressure and the Renin-Angiotensin-aldosterone system - new developments.
Front Pharmacol. 2011 Apr 27;2:22. doi: 10.3389/fphar.2011.00022. eCollection 2011.
2
Inhibition of the renin angiotensin aldosterone system: focus on aliskiren.
J Assoc Physicians India. 2010 Feb;58:102-8.
3
Optimal antagonism of the Renin-Angiotensin-aldosterone system: do we need dual or triple therapy?
Drugs. 2010 Jul 9;70(10):1215-30. doi: 10.2165/11537910-000000000-00000.
4
Dynamic Changes in the Renin-Angiotensin-Aldosterone System and the Beneficial Effects of Renin-Angiotensin-Aldosterone Inhibitors on Spatial Learning and Memory in a Rat Model of Chronic Cerebral Ischemia.
Front Neurosci. 2017 Jun 23;11:359. doi: 10.3389/fnins.2017.00359. eCollection 2017.
5
Effects of Renin-Angiotensin-Aldosterone System Inhibition on Left Ventricular Hypertrophy, Diastolic Function, and Functional Status in Patients With Hypertrophic Cardiomyopathy: A Systematic Review.
Cureus. 2022 Jul 7;14(7):e26642. doi: 10.7759/cureus.26642. eCollection 2022 Jul.
6
[Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
Vnitr Lek. 2007 Apr;53(4):364-70.
7
Inhibition of the renin-angiotensin-aldosterone system for cerebrorenal protection.
Contrib Nephrol. 2013;179:7-14. doi: 10.1159/000346717. Epub 2013 May 3.
8
The renin-angiotensin-aldosterone system, neurohumoral axis and cardiovascular mortality in LURIC.
J Clin Hypertens (Greenwich). 2022 Dec;24(12):1587-1597. doi: 10.1111/jch.14593. Epub 2022 Nov 9.
9
Hypertension: renin-angiotensin-aldosterone system alterations.
Circ Res. 2015 Mar 13;116(6):960-75. doi: 10.1161/CIRCRESAHA.116.303587.
10
Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors.
Clin J Am Soc Nephrol. 2010 Mar;5(3):531-48. doi: 10.2215/CJN.07821109. Epub 2010 Feb 11.
引用本文的文献
1
Development of lisinopril radioconjugates for nuclear imaging of the angiotensin converting enzyme.
Eur J Nucl Med Mol Imaging. 2025 Jun 7. doi: 10.1007/s00259-025-07386-w.
2
The AT/AT Receptor Equilibrium Is a Cornerstone of the Regulation of the Renin Angiotensin System beyond the Cardiovascular System.
Molecules. 2023 Jul 18;28(14):5481. doi: 10.3390/molecules28145481.
本文引用的文献
1
Contribution of bradykinin receptors to the development of secondary brain damage after experimental subarachnoid hemorrhage.
Neurosurgery. 2011 Apr;68(4):1118-23. doi: 10.1227/NEU.0b013e31820a0024.
2
Aliskiren in the treatment of hypertension and organ damage.
Cardiovasc Ther. 2011 Feb;29(1):77-87. doi: 10.1111/j.1755-5922.2010.00230.x. Epub 2010 Nov 25.
3
Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies.
Lancet Neurol. 2011 Jan;10(1):43-53. doi: 10.1016/S1474-4422(10)70250-7. Epub 2010 Oct 25.
4
Of fads, fashion, surrogate endpoints and dual RAS blockade.
Eur Heart J. 2010 Sep;31(18):2205-8. doi: 10.1093/eurheartj/ehq255. Epub 2010 Aug 3.
5
Effects of suboptimal doses of the AT1 receptor blocker, telmisartan, with the angiotensin-converting enzyme inhibitor, ramipril, on cerebral arterioles in spontaneously hypertensive rat.
J Hypertens. 2010 Jul;28(7):1566-73. doi: 10.1097/hjh.0b013e328339f1f3.
6
Reduced cerebrovascular remodeling and functional impairment in spontaneously hypertensive rats following combined treatment with suboptimal doses of telmisartan and ramipril: is less really more?
J Hypertens. 2010 Jul;28(7):1384-9. doi: 10.1097/HJH.0b013e32833c03fe.
7
Novel therapeutic targets for hypertension.
Nat Rev Cardiol. 2010 Aug;7(8):431-41. doi: 10.1038/nrcardio.2010.85. Epub 2010 Jun 22.
8
Renin angiotensin system gene polymorphisms and cerebral blood flow regulation: the MOBILIZE Boston study.
Stroke. 2010 Apr;41(4):635-40. doi: 10.1161/STROKEAHA.109.572669. Epub 2010 Feb 25.
9
ANGIOTONIN-ACTIVATOR, RENIN- AND ANGIOTONIN-INHIBITOR, AND THE MECHANISM OF ANGIOTONIN TACHYPHYLAXIS IN NORMAL, HYPERTENSIVE, AND NEPHRECTOMIZED ANIMALS.
J Exp Med. 1940 Mar 31;71(4):495-519. doi: 10.1084/jem.71.4.495.
10
Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design.
Nephrol Dial Transplant. 2009 May;24(5):1663-71. doi: 10.1093/ndt/gfn721. Epub 2009 Jan 14.
Zotero 插件
